Safety check for ongoing autoimmune drug treatment

NCT ID NCT04638647

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study monitors the long-term safety of secukinumab, a medication for autoimmune and inflammatory conditions. It's for people who have already been taking secukinumab in a previous Novartis study and need to continue treatment but can't get it through regular prescriptions. The main goal is to track any side effects that might occur with extended use.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-••••

Locations

Accurate Clinical Research Inc
ACTIVE_NOT_RECRUITING

San Antonio, Texas, 78229, United States
Ahmed Arif Medical Research Center
COMPLETED

Grand Blanc, Michigan, 48439, United States
Altoona Center for Clin Res
ACTIVE_NOT_RECRUITING

Duncansville, Pennsylvania, 16635, United States
Arthritis Rheumatology and Bone Disease Associates PA
COMPLETED

Voorhees Township, New Jersey, 08043, United States
Austin Regional Clinic Rheumatology
COMPLETED

Austin, Texas, 78731, United States
Center for Rheumatology Research
COMPLETED

West Hills, California, 91307, United States
Conquest Research
COMPLETED

Winter Park, Florida, 32789, United States
Dawes Fretzin Clinical Rea Group
COMPLETED

Indianapolis, Indiana, 46256, United States
Denver Arthritis Clinic
COMPLETED

Denver, Colorado, 80230, United States
FL Medical Clinic Orlando Health
RECRUITING

Zephyrhills, Florida, 33542, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Homestead Assoc In Research Inc
COMPLETED

Homestead, Florida, 33033, United States
IRIS Research and Development
COMPLETED

Plantation, Florida, 33324, United States
Inland Rheumatology Clinical Trials INC
COMPLETED

Upland, California, 91786, United States
Klein and Associates
COMPLETED

Hagerstown, Maryland, 21740, United States
Medvin Clinical Research
COMPLETED

Van Nuys, California, 91405, United States
Novartis Investigative Site
COMPLETED

Vitória, Espírito Santo, 29055 450, Brazil
Novartis Investigative Site
COMPLETED

Salvador, Estado de Bahia, 40150 150, Brazil
Novartis Investigative Site
COMPLETED

Juiz de Fora, Minas Gerais, 36010 570, Brazil
Novartis Investigative Site
COMPLETED

São Paulo, São Paulo, 01244-030, Brazil
Novartis Investigative Site
COMPLETED

São Paulo, São Paulo, 04266 010, Brazil
Novartis Investigative Site
COMPLETED

Rio de Janeiro, 20241-180, Brazil
Novartis Investigative Site
COMPLETED

Sao Jose Rio Preto, 15090 000, Brazil
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Pleven, 5800, Bulgaria
Novartis Investigative Site
COMPLETED

Plovdiv, 4002, Bulgaria
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Sofia, 1407, Bulgaria
Novartis Investigative Site
COMPLETED

Sofia, 1431, Bulgaria
Novartis Investigative Site
COMPLETED

Sofia, 1784, Bulgaria
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Stara Zagora, 6000, Bulgaria
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Hefei, Anhui, 230001, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Hefei, Anhui, 230601, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Beijing, Beijing Municipality, 100044, China
Novartis Investigative Site
COMPLETED

Chongqing, Chongqing Municipality, 400010, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Xiamen, Fujian, 361001, China
Novartis Investigative Site
COMPLETED

Guangzhou, Guangdong, 510030, China
Novartis Investigative Site
COMPLETED

Guangzhou, Guangdong, 510120, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Guangzhou, Guangdong, 510515, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Shantou, Guangdong, 515000, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Shenzhen, Guangdong, 518020, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Wuhan, Hubei, 430030, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Changsha, Hunan, 410011, China
Novartis Investigative Site
COMPLETED

Zhuzhou, Hunan, 412000, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Baotou, Inner Mongolia, 014010, China
Novartis Investigative Site
COMPLETED

Hohhot, Inner Mongolia, 010050, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Nanjing, Jiangsu, 210008, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Nanjing, Jiangsu, 210009, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Yangzhou, Jiangsu, 225001, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Nanchang, Jiangxi, 330006, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Pingxiang, Jiangxi, 337000, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Changchun, Jilin, 130021, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Linyi, Shandong, 276000, China
Novartis Investigative Site
COMPLETED

Chengdu, Sichuan, 610041, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Ürümqi, Xinjiang, 830001, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Kunming, Yunnan, 650000, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Ningbo, Zhejiang, 315016, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Wenzhou, Zhejiang, 325000, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Beijing, 100000, China
Novartis Investigative Site
COMPLETED

Beijing, 100050, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Beijing, 100730, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Bengbu, 233004, China
Novartis Investigative Site
COMPLETED

Jinan, 250012, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Shanghai, 200040, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Shanghai, 200050, China
Novartis Investigative Site
COMPLETED

Shanghai, 200127, China
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Tianjin, 300052, China
Novartis Investigative Site
COMPLETED

Bogota, Cundinamarca, 110221, Colombia
Novartis Investigative Site
COMPLETED

Chía, Cundinamarca, 250001, Colombia
Novartis Investigative Site
COMPLETED

Bucaramanga, Santander Department, 680003, Colombia
Novartis Investigative Site
COMPLETED

Ibagué, Tolima Department, 730006, Colombia
Novartis Investigative Site
RECRUITING

Ostrava, Czech Republic, 772 00, Czechia
Novartis Investigative Site
RECRUITING

Brno-Zidonice, CZE, 61500, Czechia
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Prague, Prague 1, 11000, Czechia
Novartis Investigative Site
RECRUITING

Brno, 625 00, Czechia
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Hradec Králové, 500 05, Czechia
Novartis Investigative Site
RECRUITING

Prague, 128 00, Czechia
Novartis Investigative Site
RECRUITING

Prague, 140 59, Czechia
Novartis Investigative Site
RECRUITING

Prague, 148 00, Czechia
Novartis Investigative Site
RECRUITING

Prague, 150 06, Czechia
Novartis Investigative Site
RECRUITING

Uherské Hradiště, 686 01, Czechia
Novartis Investigative Site
WITHDRAWN

Pátrai, 26443, Greece
Novartis Investigative Site
COMPLETED

Guatemala City, 01001, Guatemala
Novartis Investigative Site
COMPLETED

Guatemala City, 01009, Guatemala
Novartis Investigative Site
COMPLETED

Guatemala City, 01010, Guatemala
Novartis Investigative Site
COMPLETED

Guatemala City, 01011, Guatemala
Novartis Investigative Site
COMPLETED

Surat, Gujarat, 395009, India
Novartis Investigative Site
COMPLETED

Bangalore, Karnataka, 560 079, India
Novartis Investigative Site
COMPLETED

Mumbai, Maharashtra, 400 053, India
Novartis Investigative Site
COMPLETED

Nashik, Maharashtra, 422101, India
Novartis Investigative Site
COMPLETED

Hyderabad, Telangana, 500082, India
Novartis Investigative Site
COMPLETED

New Delhi, 110029, India
Novartis Investigative Site
COMPLETED

Florence, FI, 50134, Italy
Novartis Investigative Site
COMPLETED

Reggio Emilia, RE, 42123, Italy
Novartis Investigative Site
COMPLETED

Kuching, Sarawak, 93586, Malaysia
Novartis Investigative Site
COMPLETED

Kuala Lumpur, 59100, Malaysia
Novartis Investigative Site
COMPLETED

Guadalajara, Jalisco, 44160, Mexico
Novartis Investigative Site
COMPLETED

Culiacan, State of Mexico, 80000, Mexico
Novartis Investigative Site
COMPLETED

Metepec, State of Mexico, 52140, Mexico
Novartis Investigative Site
COMPLETED

Krakow, Lesser Poland Voivodeship, 30-727, Poland
Novartis Investigative Site
COMPLETED

Wroclaw, Lower Silesian Voivodeship, 52-210, Poland
Novartis Investigative Site
COMPLETED

Bialystok, 15-351, Poland
Novartis Investigative Site
RECRUITING

Bydgoszcz, 85-168, Poland
Novartis Investigative Site
RECRUITING

Krakow, 30-002, Poland
Novartis Investigative Site
COMPLETED

Poznan, 60-218, Poland
Novartis Investigative Site
COMPLETED

Sochaczew, 96-500, Poland
Novartis Investigative Site
RECRUITING

Torun, 87-100, Poland
Novartis Investigative Site
COMPLETED

Warsaw, 02-118, Poland
Novartis Investigative Site
COMPLETED

Warsaw, 02-637, Poland
Novartis Investigative Site
COMPLETED

Warsaw, 02-962, Poland
Novartis Investigative Site
COMPLETED

Warsaw, 04-305, Poland
Novartis Investigative Site
COMPLETED

Wroclaw, 53-224, Poland
Novartis Investigative Site
COMPLETED

Lisbon, 1649-035, Portugal
Novartis Investigative Site
COMPLETED

Barnaul, 656024, Russia
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Chelyabinsk, 454048, Russia
Novartis Investigative Site
COMPLETED

Kazan', 420012, Russia
Novartis Investigative Site
COMPLETED

Kazan', 420064, Russia
Novartis Investigative Site
COMPLETED

Kemerovo, 650029, Russia
Novartis Investigative Site
COMPLETED

Kemerovo, 650070, Russia
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Krasnodar, 350020, Russia
Novartis Investigative Site
COMPLETED

Moscow, 115522, Russia
Novartis Investigative Site
COMPLETED

Moscow, 119296, Russia
Novartis Investigative Site
COMPLETED

Moscow, 127473, Russia
Novartis Investigative Site
COMPLETED

Saint Petersburg, 190068, Russia
Novartis Investigative Site
COMPLETED

Saint Petersburg, 197022, Russia
Novartis Investigative Site
COMPLETED

Saint Petersburg, 197198, Russia
Novartis Investigative Site
RECRUITING

Saint Petersburg, 197198, Russia
Novartis Investigative Site
COMPLETED

Saint Petersburg, 197341, Russia
Novartis Investigative Site
COMPLETED

Saratov, 410053, Russia
Novartis Investigative Site
COMPLETED

Smolensk, 214019, Russia
Novartis Investigative Site
COMPLETED

Ulyanovsk, 432063, Russia
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Yaroslavl, 150003, Russia
Novartis Investigative Site
COMPLETED

Yaroslavl, 150054, Russia
Novartis Investigative Site
COMPLETED

Yekaterinburg, 620023, Russia
Novartis Investigative Site
COMPLETED

Yekaterinburg, 620028, Russia
Novartis Investigative Site
COMPLETED

Panorama, Western Cape, 7500, South Africa
Novartis Investigative Site
COMPLETED

Stellenbosch, Western Cape, 7600, South Africa
Novartis Investigative Site
COMPLETED

Seoul, Korea, 03080, South Korea
Novartis Investigative Site
COMPLETED

Seoul, 06351, South Korea
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Santiago Compostela, A Coruna, 15706, Spain
Novartis Investigative Site
COMPLETED

Málaga, Andalusia, 29009, Spain
Novartis Investigative Site
COMPLETED

L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Novartis Investigative Site
COMPLETED

Bilbao, Bizkaia, 48013, Spain
Novartis Investigative Site
COMPLETED

Santander, Cantabria, 39008, Spain
Novartis Investigative Site
COMPLETED

Vigo, Pontevedra, 36214, Spain
Novartis Investigative Site
COMPLETED

A Coruña, 15006, Spain
Novartis Investigative Site
RECRUITING

Madrid, 28009, Spain
Novartis Investigative Site
COMPLETED

Madrid, 28009, Spain
Novartis Investigative Site
COMPLETED

Madrid, 28041, Spain
Novartis Investigative Site
RECRUITING

Madrid, 28046, Spain
Novartis Investigative Site
COMPLETED

Madrid, 28046, Spain
Novartis Investigative Site
WITHDRAWN

Seville, 41009, Spain
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Valencia, 46026, Spain
Novartis Investigative Site
COMPLETED

Valencia, 46026, Spain
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Basel, 4031, Switzerland
Novartis Investigative Site
ACTIVE_NOT_RECRUITING

Bern, 3010, Switzerland
Novartis Investigative Site
COMPLETED

Sankt Gallen, 9007, Switzerland
Oregon Health Sciences University
COMPLETED

Portland, Oregon, 97239, United States
Orrin Troum MD and Medical Associates
COMPLETED

Santa Monica, California, 90404, United States
Overlake Arthritis and Osteoporosis
COMPLETED

Bellevue, Washington, 98004, United States
Physician Research Collaboration
COMPLETED

Lincoln, Nebraska, 68516, United States
Precn Comprehensive Clnl Rsch Solns
COMPLETED

San Leandro, California, 94578, United States
Providence Medical Foundation
COMPLETED

Fullerton, California, 92835, United States
Purushotham Akther and Roshan Kotha MD Inc
COMPLETED

La Mesa, California, 91942, United States
Rheumatology Associates of South Florida
RECRUITING

Boca Raton, Florida, 33486, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Rheumatology Pulmonary Clinic
COMPLETED

Beckley, West Virginia, 25801, United States
Southwest Rheum Rsrch LLC
COMPLETED

Mesquite, Texas, 75150, United States
St Lawrence Health System
COMPLETED

Potsdam, New York, 13676, United States
West Tennessee Research Institute
RECRUITING

Jackson, Tennessee, 38305, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Willow Rheumatology Wellness
COMPLETED

Willowbrook, Illinois, 60527, United States

Conditions

Explore the condition pages connected to this study.

AUTOIMMUNITY, INFLAMMATION